Tag: strategic-review

Caribou Biosciences Plans a Substantial Workforce Reduction as It Halts Two CAR-T Programs

Caribou Biosciences plans a substantial workforce reduction as it stops development of its two allogeneic CAR-T therapy programs and begins a review of strategic alternatives.